Antiviral Agents in Development for Zika Virus Infections

Pharmaceuticals - Switzerland
doi 10.3390/ph12030101
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

MDPI AG

Related search

Recent Advances in Process Development of Antiviral Agents Targeting the Influenza Virus: Amantadine-RemantadineDerived Pharmaceutical Agents

Open Access Journal of Pharmaceutical Research
2018English

Macromolecular Antiviral Agents Against Zika, Ebola, SARS, and Other Pathogenic Viruses

Advanced healthcare materials
Biomedical EngineeringBiomaterialsPharmaceutical Science
2017English

Zika Virus Production Is Resistant to RNase L Antiviral Activity

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2019English

Diagnostic Accuracy of Parameters for Zika and Dengue Virus Infections, Singapore

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2017English

ABC of AIDS: Treatment of Infections and Antiviral Agents

BMJ
1987English

Orthopoxvirus Targets for the Development of New Antiviral Agents

Antiviral Research
VirologyPharmacology
2012English

Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus

Viruses
VirologyInfectious Diseases
2018English

Current Views on Zika Virus Vaccine Development

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2017English

Deconvolution of Pro- And Antiviral Genomic Responses in Zika Virus-Infected and Bystander Macrophages

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy